Great discussions on outcomes and patient selection for Convergent Procedure AFib Emory #EPeeps

I don’t know too much about the people of Poland, but I am impressed with their willingness to help Ukrainians. Go Poland!

Join us for the next Virtual #MedEd Program & peer-to-peer discussion led by David DeLurgio, Paul Mahoney & Sean Pokorney on the most recent and largest real-world data release by the ACC NCDR #LAAO Registry. Reserve your spot for the June 15 program: bit.ly/3xcPpau

New on EDUCARE: Hear from Drs. David DeLurgio, Paul Mahoney, and Sean Pokorney on the most recent and largest real-world data release by the ACC NCDR #LAAO Registry. Watch on-demand: bit.ly/3dbG0tA #LAAC #MedEd

Efficacy in persistent AF patients   - PVI: 53% - PVI + Endo LAPWI: 54% - PVI+ Endo-Epi LAPWI: 68%   Endo/Epi dissociation and poor transmurality do impact endo-only results. #EPPeeps #HybridAFTherapy @atricure What is your approach to treating advanced AF patients?

What do you think? Felix Yang, MD, FACC, FHRS Roderick Tung Kevin J Makati Christopher Ellis @EPwoodsShop Andrea Russo Hugh Calkins @NiteshSoodMD AFib Emory JICE StopAfib.org

Excited for the opportunity to explore "pill in pocket" anticoagulation for AF in the NIH-funded pivotal REACT-AF trial. Thank you to our partners NM Cardiovascular , Stanford Medicine, UCSF School of Medicine, NUCATS Institute, Trial Innovations , American Heart Association, Apple

Its a privilege to be training Emory Cardiology with David DeLurgio to experience PFA firsthand. #EPeeps #varipulse #AdmIREtrial @BiosenseWebster

The California Heart Rhythm Symposium is just kicking off at UCLA! Excited to hear premier speakers on latest arrhythmia advances AFib Emory AtriCure, Inc. #EPeeps

Thank you to the attendees, faculty, & partnership BostonSci Cardiology for the forum to discuss all things AF. Critical time in EP as we define AF management together. Dr. Devi G Nair Wilber Su Atul Verma Luigi Di Biase David DeLurgio Edward Gerstenfeld Kenneth Stein

BREAKING: #HRStv host Daniel Alyesh is joined by peterkistler MBBS PhD FHRS and David DeLurgio for part III of their discussion on ERAS-AF. A randomized study of pursuing substrate based approach for non-pulmonary vein triggers. See more here #EPeeps ➡️ bit.ly/3kBhKox

Hybrid epicardial-endocardial ablation for long-standing persistent atrial fibrillation: A subanalysis of the CONVERGE Trial. David DeLurgio heartrhythmopen.com/article/S2666-…

Although a couple years old, this JICRM article about ICE-guided site-specific transseptal puncture by Faisal Merchant and David DeLurgio is still very instructive innovationsincrm.com/cardiac-rhythm…

A robust heart team approach and optimizing patient selection are critical when determining risk and benefit of performing hybrid convergent ablation. # link.springer.com/article/10.100…

According to a recent publication from David DeLurgio, identifying the right patient for the Hybrid Convergent approach and optimizing procedural details are important aspects of managing a Hybrid program. Keep reading: bit.ly/4399rAJ​ ISI: bit.ly/EpiSenseST

With AtriCure, Inc. Medical Director Randy Lee, Michael Thomas, Blake Fitzgerald, Noah Beller, Hannah Heaton and physician faculty who are leading discussions, case observations and peer-to-peer learning at the Advanced Hybrid AF Convergent Therapy course in California today. #education

DJ Lakkireddy European Society of Cardiology Andrea Natale MD Vivek Y. Reddy John Mandrola, MD American College of Cardiology Heart Rhythm Society I think an important figure (suppl) is the procedure time - 20 mins shorter than RF. PFA procedure took 105 mins, including 20 min wait - so really 85 min with a new tech. Same outcome and no risk of LA/eso fistula, phrenic injury or PV stenosis make it an important advance IMHBO

Sub-analysis from the CONVERGE Trial demonstrates Hybrid Convergent procedure reduced Afib symptoms, significantly improved quality of life and reduced anti-arrhythmic drug use from baseline in advanced Afib patients #hybridaftherapy#atricure annalscts.com/article/view/1…

7/ Congrats to Dr. David DeLurgio who also completed his 1st WATCHMAN FLX Pro implant today! Thank you to Dr. DeLurgio and the team at Emory St. Joseph’s Hospital for your dedication to advancing #LAAC therapy for your #AFib patients.

Thrilled to be at the forefront of Abbott’s PFA technology and leading enrollments in their VOLT PFA IDE Clinical Trial! ⚡️ Emory Cardiology  @DavidBDelurgio @SaintJosephsATL  AFib Emory Emory Department of Medicine SHANNON MILLARD  Sarah Peter #EPeeps ❤️